Lars Birgerson

Lars Birgerson has extensive work experience in the medical industry. Lars began their career in 1998 at Pharmacia as Group Vice President Global Medical Affairs. In 2003, they moved to Roche Pharmaceuticals where they held the roles of Head Global Medical Affairs and VP US Medical Affairs Roche. From 2009 to 2012, Birgerson worked at Genentech as VP Medical Affairs. Lars then moved to Bristol-Myers Squibb as SVP Global Medical from 2012 to 2016. In 2016, Birgerson founded The Birgerson Group LLC and served as President & Senior Advisor. In 2018, they became President & Chief Executive Officer of Adlai Nortye USA Inc. and Chief Development Officer of Adlai Nortye Biopharma Co., Ltd.

Lars Birgerson obtained an M.D. Ph.D. from Uppsala University.